Moberg Pharma completes divestment of PediaCare for $5.6 million
STOCKHOLM, December 20th, 2016. Moberg Pharma AB (OMX: MOB) announces that the company has completed the divestment of the PediaCare® brand to Strides Arcolab International Limited, UK for a total consideration of $5.6 million, whereof $0.6 million comprises inventory value.Moberg Pharma’s strategy is to build value through profitable growth of strategic brands, to increase the value of pipeline assets and to make value-adding acquisitions. Divesting PediaCare® enables Moberg Pharma to focus on its core business. The divested brand originated from an acquisition in July 2016 where the